FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...

Product-specific Q Code (Q0224) facilitates product reimbursement for PEMGARDA; corresponding M Code (M0224) defines reimbursement for product administration Reimbursement through Medicare/Medicaid ...

Medical billing and coding systems ensure that health providers get paid for their services. Learn the steps in medical ...

Adjusted operating margin is projected in the range of 6% to 8%, with net income per diluted share in the range of $1.23 to $1.81 and adjusted net income per diluted share in the range of $1.85 to ...

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver ...

In the modern National Health Service (NHS), performance outcome is increasingly being compared between surgical units. These quality indices exert a significant influence on the choice of providers ...

Compensation and reimbursement plans vary widely across the healthcare system. Collections-based, dollar per relative value unit (RVU) or salary plus incentive are three of the most commonly used ...